標(biāo)題: Titlebook: Advancing Healthcare Through Personalized Medicine; Priya Hays Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), un [打印本頁] 作者: lumbar-puncture 時間: 2025-3-21 17:32
書目名稱Advancing Healthcare Through Personalized Medicine影響因子(影響力)
書目名稱Advancing Healthcare Through Personalized Medicine影響因子(影響力)學(xué)科排名
書目名稱Advancing Healthcare Through Personalized Medicine網(wǎng)絡(luò)公開度
書目名稱Advancing Healthcare Through Personalized Medicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Advancing Healthcare Through Personalized Medicine被引頻次
書目名稱Advancing Healthcare Through Personalized Medicine被引頻次學(xué)科排名
書目名稱Advancing Healthcare Through Personalized Medicine年度引用
書目名稱Advancing Healthcare Through Personalized Medicine年度引用學(xué)科排名
書目名稱Advancing Healthcare Through Personalized Medicine讀者反饋
書目名稱Advancing Healthcare Through Personalized Medicine讀者反饋學(xué)科排名
作者: engagement 時間: 2025-3-21 23:47 作者: 陳舊 時間: 2025-3-22 01:46
Patient Narratives: Personalized Medicine in the Field,sen,” was created for her rare genetic disorder, demonstrates personalized medicine at its best: one drug-one patient. As shown by other patient stories, personalized medicine has the potential to have great positive impact on patient care, as reflected in the story of Alexis and Noah Beery, twin da作者: Accomplish 時間: 2025-3-22 05:11
Alliances: Knowledge Infrastructures, and the Digitization of Precision Health,my of Disease, which produced the ground breaking document “Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease.” According to the document, to realize the full potential of precision medicine, both researchers and clinicians must have full a作者: Sputum 時間: 2025-3-22 12:40 作者: AGONY 時間: 2025-3-22 13:25
Trends in Precision Oncology and Precision Medicine 2.0,rends in precision oncology that form tangential, however still very significant, advances in personalized oncology. Liquid biopsy remains a powerful tool as a noninvasive, elegant way of determining prognosis of certain malignancies. The development of novel immunotherapies has led to the term “Pre作者: CHECK 時間: 2025-3-22 17:53
,Personalized Medicine’s Impact on Disease,inical heterogeneity precluding the development of targeted therapies for these diseases. Pharmacogenetics and genetic variation have led to safe and efficacious drugs for type II diabetes, cardiovascular diseases, neurological diseases, major depressive disorder and schizophrenia, and even COVID-19作者: 不開心 時間: 2025-3-22 21:28
The Genome in the Clinic and Boardroom: Biomarkers, Diagnosis, Treatment, and Education,fied healthcare patient populations. A number of companies in the precision medicine space are developing innovative technologies for the implementation of targeted diagnostics and therapies for patients with cancer and cardiovascular disease. They are liquid biopsy companies that enable early detec作者: 低能兒 時間: 2025-3-23 03:53 作者: 豎琴 時間: 2025-3-23 08:47
Legislation, Reimbursement, and the Regulatory Landscape,Therapy Act are recent examples of federal legislation designed to implement personalized medicine and improve access. The co-development of companion diagnostics and therapeutics must undergo rigorous review by the FDA for approval, of which there are numerous examples that have robust analytical v作者: 過分 時間: 2025-3-23 12:20 作者: infelicitous 時間: 2025-3-23 15:03 作者: coalition 時間: 2025-3-23 18:06 作者: linear 時間: 2025-3-24 01:27
Conclusion,of significant gains. Precision medicine has led to spectacular gains in health care, accompanied by the “digitization” of health enabling big data from whole genome sequencing, whole exome sequencing, and targeted gene panels to be curated by large databases for accurate and convenient interpretabi作者: hieroglyphic 時間: 2025-3-24 03:36 作者: 極小量 時間: 2025-3-24 09:49 作者: Texture 時間: 2025-3-24 11:54
Advancing Healthcare Through Personalized Medicine作者: Transfusion 時間: 2025-3-24 15:04 作者: 緩和 時間: 2025-3-24 22:33
The Rise of Genomics and Personalized Medicine,e in the process of pharmacogenomics testing, diagnosis, and treatment, and patients and physicians must be encouraged to accept pharmacogenomics. As a corollary effect of genomic efforts, biomarkers (mainly genetic) are being discovered which aid greatly in determining appropriate targeted treatmen作者: 拉開這車床 時間: 2025-3-25 01:34 作者: defile 時間: 2025-3-25 04:28
Alliances: Knowledge Infrastructures, and the Digitization of Precision Health,rse mechanisms..Digital Health, in the form of Electronic Health Records, Big Data, and artificial intelligence, can potentially lead to more efficient healthcare delivery and necessitates an infrastructure/system to store and manage the vast amount of data that result from next-generation sequencin作者: 肉身 時間: 2025-3-25 08:01
Great Strides in Precision Medicine: Personalized Oncology, Immunotherapies, and Molecular Diagnostnted in this chapter demonstrating significant clinical outcomes, and where primary endpoints such as overall survival and progression-free survival are met. Liquid biopsy has proved to be a notable alternative to tissue biopsy, and is able to provide longitudinal monitoring of malignancies. In shor作者: 剝皮 時間: 2025-3-25 15:29
A New Set of Clinical Tools for Physicians,viders, are now becoming the norm in major medical centers to provide comprehensive cancer care for patients. Thus, the innovative toolkit now available to stakeholders through personalized medicine will likely lead to robust clinical outcomes for patients and their families.作者: 樹上結(jié)蜜糖 時間: 2025-3-25 16:59
Translational Personalized Medicine: Molecular Profiling, Druggable Targets, and Clinical Genomic M, Lynch syndrome, and connective tissue disorders is proving to have high diagnostic yield. Innovative companies such as Translational Software are changing the paradigm by which pharmacogenomic testing is conducted and thereby improving the quality of life for physicians and patients and Genomic Ex作者: 令人作嘔 時間: 2025-3-25 21:34 作者: GRE 時間: 2025-3-26 01:27 作者: 極為憤怒 時間: 2025-3-26 06:14
Book 2021Latest editionThe book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence.?.A work that advocates for a patient-centered approach,?.Advancing Healthcare Through Personalized Medicine, Second Edition.?is an invaluable text for 作者: 畏縮 時間: 2025-3-26 10:02 作者: Instantaneous 時間: 2025-3-26 15:57 作者: tariff 時間: 2025-3-26 20:00 作者: 表否定 時間: 2025-3-27 00:11
Continuous Transcutaneous Monitoringnted in this chapter demonstrating significant clinical outcomes, and where primary endpoints such as overall survival and progression-free survival are met. Liquid biopsy has proved to be a notable alternative to tissue biopsy, and is able to provide longitudinal monitoring of malignancies. In shor作者: Somber 時間: 2025-3-27 01:39 作者: 沒有希望 時間: 2025-3-27 05:27 作者: curriculum 時間: 2025-3-27 11:24 作者: 雄辯 時間: 2025-3-27 15:17
https://doi.org/10.1007/BFb0071569east cancer, melanoma, colorectal cancer, prostate cancer hematological malignancies, and central nervous system tumors, among other tumor subtypes, accompanied by relatively low grade adverse events.作者: aplomb 時間: 2025-3-27 17:45 作者: 涂掉 時間: 2025-3-28 00:08 作者: 狼群 時間: 2025-3-28 02:26 作者: CROW 時間: 2025-3-28 07:18 作者: muffler 時間: 2025-3-28 13:17 作者: grenade 時間: 2025-3-28 18:10 作者: 強制令 時間: 2025-3-28 21:04
Differentiable transformations in ,inical heterogeneity precluding the development of targeted therapies for these diseases. Pharmacogenetics and genetic variation have led to safe and efficacious drugs for type II diabetes, cardiovascular diseases, neurological diseases, major depressive disorder and schizophrenia, and even COVID-19作者: CULP 時間: 2025-3-28 23:14
Differentiable transformations in ,fied healthcare patient populations. A number of companies in the precision medicine space are developing innovative technologies for the implementation of targeted diagnostics and therapies for patients with cancer and cardiovascular disease. They are liquid biopsy companies that enable early detec作者: 6Applepolish 時間: 2025-3-29 05:51 作者: eczema 時間: 2025-3-29 08:03 作者: Pantry 時間: 2025-3-29 14:04
Concrete and Reinforced Concrete Behaviour,. Genetic testing infrastructures are being created, involving thousands of participants, such as BioVU, PREDICT, BioMe, CLIPMERGE, and the MyCode Community Health Initiative that would enable the development of clinical utility for genetic testing and screening. Basic genomic research, particularly作者: CHURL 時間: 2025-3-29 17:31 作者: 袋鼠 時間: 2025-3-29 21:45
https://doi.org/10.1007/BFb0071569lied to translational genomic research and the All of Us Research Program. Population of one intervention has required new ethical guidelines, where traditional trial participation and drug development paradigms are being transformed. Protecting the privacy of an individual’s genomic data and ensuri作者: 傲慢物 時間: 2025-3-30 01:19
https://doi.org/10.1007/BFb0071569of significant gains. Precision medicine has led to spectacular gains in health care, accompanied by the “digitization” of health enabling big data from whole genome sequencing, whole exome sequencing, and targeted gene panels to be curated by large databases for accurate and convenient interpretabi作者: 打折 時間: 2025-3-30 07:12 作者: 剛開始 時間: 2025-3-30 11:48
